- Bupa Platinum consultant
- Fee assured
- Verified account
- Open Referral network
Albert Edwards is a consultant clinical oncologist who delivers non-surgical treatments to people with urological cancers. My specialist interests are prostate brachytherapy, image-guided IMRT radiotherapy and inserting SpaceOAR hydrogel spacers for patients receiving prostate radiotherapy, prostate brachytherapy or a combination of both.
I undertook a radiation oncology clinical fellowship at Princess Margaret Hospital in Toronto, Canada and a prostate brachytherapy fellowship at the Royal Surrey County Hospital, Guildford.
Areas of interest
Prostate Brachytherapy; Prostate Radiotherapy; IGRT; IMRT; SpaceOAR implant; Bladder Radiotherapy; Bladder Chemoradiation
Current NHS consultant posts held
Consultant Clinical Oncologist working for Maidstone and Tunbridge Wells NHS Trust at
Kent Oncology Centre, Kent & Canterbury Hospital.
Poster 3537: Intensity-Modulated Chemoradiation for Anal Cancer: A South-East UK experience. Int J Radiat Oncol Biol Phys 2020: 108(3S):e663–e664.
Evolving Trends in Kidney Cancer, chap. Medical Management of Renal Cell Cancer. 10. IntechOpen, 2020
Establishing international variation in target delineation using MRI for bladder radiotherapy. Radiother Oncol 2019: 133(Supp 1):S857–S858.
Brachytherapy for the Urologist: A multidisciplinary team update for 2019. J Clin Urol 2019: 12(1):1–9.
1162 - Urinary symptoms in the first year after I-125 implantation for prostate cancer: Does 4D intraoperative dose planning improve LUTS. Eur Urol Suppl 2018: 17(2):e1637.
Kent experience of radical chemoradiotherapy for muscle invasive bladder cancer. J Clin Oncol 2017: 35(Supplement 6):373.
Chapter 43, Urological Oncology: Brachytherapy for Prostate Cancer, 743–772. Springer London, London, 2nd edn.
Does prostate HistoScanningTM play a role in detecting prostate cancer in routine clinical practice? Results from three independent studies. BJU Int 2014: 114(4):541–548.
A Competing Risks Analysis of Clinical Outcomes of Prostate LDR Brachytherapy at a Single Institution. Int J Radiat Oncol Biol Phys 2014: 90(1):S415.
Favourable long-term outcomes with brachytherapy-based regimens in men ≤60 years with clinically localized prostate cancer. BJU Int 2013: 111(8):1181– 1182.
Chapter 8, Specialist Training in Oncology: Head and Neck Cancer
The developing role for intensity-modulated radiation therapy (IMRT) in the non-surgical treatment of brain metastases. Br J Radiol 2010: 83(986):133–136.
Focal radiation therapy for patients with persistent/recurrent pituitary adenoma, despite previous radiotherapy. Pituitary 2009: 12(1):30–34.
- BSc (Intercalated): Neuroscience University College London 1996
- MRCP(UK) Royal College of Physicians, London 2004
- FRCR Royal College of Radiologists 2009
- Prostate Brachytherapy Research Fellowship Royal Surrey County Hospital, Guildford 2012
- Head and Neck Radiation Oncology Clinical Fellowship Department of Radiation Oncology, Princess Margaret Hospital, Toronto, Ontario, Canada 2010
Reference number 4628578
Details of entry to specialist register
- Clinical Oncology , 2012
Affiliations / memberships
Royal College of Radiologists
British Uro-Oncology Group (BUG)
Hospital Consultant and Specialist Association
Medical Protection Society
Post treatment communication
Information for healthcare professionals (Bupa patients only, last 12 months)
Insertion of low dose rate radioactive agent (brachytherapy) into prostate tumour - (1-5)
Planning for insertion and removal of high dose rate radioactive agent (brachytherapy) into prostate tumour - (1-5)